Prime is excited to announce the release of the 2025 Prime Therapeutics Report! The 2025 edition of the Prime Therapeutics Report delivers key insights, trend highlights and strategies for specialty management to help you make the best decisions for you and your members. You'll see articles such as:
Autoimmune management: Biosimilar update and challenges in management
Precision oncology: Evaluating real-world operational process of biomarker testing
Gene therapy: Advancement and management in challenges
Prime Therapeutics IntegratedRx®: Oncology and cystic fibrosis solutions
GLP-1 update: Increased utilization and market impacts
We hope you gain valuable insights from this 2025 Prime Therapeutics Report.